Biotech startups in The Netherlands
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Cradle | Delft | Series B | $73.0M | 2024-11-26 |
| Kynexis | Naarden | Series A | $112.3M | 2026-08-19 |
| Vico Therapeutics | Leiden | Series B | $12.3M | 2024-06-24 |
| VectorY | Amsterdam | Series A | $138.0M | 2023-11-13 |
| Matisse Pharmaceuticals | Geleen | Series A | $16.0M | 2026-09-17 |
| Qorium | Maastricht | Series A | $25.5M | 2025-11-11 |
| OASYS NOW | Delft | Seed | $1.0M | 2024-11-22 |
| VSPARTICLE | Delft | Series A | $7.1M | 2024-08-08 |
8 rows of the CSV in 5 of its 18 columns.
- The 124 biotech startups in The Netherlands have raised $1.4B in total.
- 12 of them closed their most recent round in the last 12 months, $274.5M combined.
- The largest of those rounds is Kynexis' $112.3M Series A, dated August 2026.
- The most recent is Anaheim Bio's $44.9M Series A on 5 November 2026.
- Forbion Capital Partners is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 80 companies (65%).
- 33% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (52% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
16 of 124| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Matisse Pharmaceuticals | Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. | Biotech | Geleen | Series A | $16.0M | 2026-09-17 | $22.0M | Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) | 11 to 50 | 2014 |
| Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden | Series A | $112.3M | 2026-08-19 | $173.3M | Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures | 11 to 50 | 2023 |
| Pan Cancer T | Pan Cancer T develops T-cell receptor therapies for treating solid tumors. | Biotech | Rotterdam | Seed | $5.8M | 2025-12-08 | $16.3M | InnovationQuarter, Thuja Capital, Van Herk Ventures +1 | 1 to 10 | 2020 |
| Qorium | Qorium makes reinvented real leather materials. | Biotech | Maastricht | Series A | $25.5M | 2025-11-11 | $28.6M | Sofinnova Partners, Brightlands Venture Partners | 11 to 50 | 2021 |
| CryoCloud | CryoCloud provides cloud-based cryo-EM image analysis for protein structure determination. | Biotech | Utrecht | Seed | $2.3M | 2025-05-06 | $2.8M | Nina Capital, ROM Utrecht Region, Utrecht Health Seed Fund | 1 to 10 | 2021 |
| Cradle | Cradle uses AI prediction algorithms to help biologists design proteins. | Artificial intelligence | Delft | Series B | $73.0M | 2024-11-26 | Index Ventures, IVP, Kindred Capital | 11 to 50 | 2021 | |
| OASYS NOW | OASYS NOW is a medtech startup that uses AI to improve clinical trial recruitment. | Artificial intelligence | Delft | Seed | $1.0M | 2024-11-22 | Graduate Ventures, ASIF Ventures, TenNine VC | 1 to 10 | 2021 | |
| VSPARTICLE | VSPARTICLE makes nanoparticle generators for sensors, batteries, catalysis, solar cells, and other uses. | Biotech | Delft | Series A | $7.1M | 2024-08-08 | BlueYard Capital, MIT delta v, NordicNinja VC +2 | 11 to 50 | 2014 | |
| Vico Therapeutics | Vico Therapeutics develops RNA modulating therapies. | Biotech | Leiden | Series B | $12.3M | 2024-06-24 | $115.4M | Polaris Partners, Eurazeo, EQT Life Sciences +2 | 11 to 50 | 2019 |
| MindAffect | MindAffect develops brain-computer interfaces for medical applications. | Artificial intelligence | Nijmegen | Series A | $1.2M | 2024-04-29 | NLC, Wasteland Investments, Barco Limpo | 1 to 10 | 2017 | |
| IridescentBio | IridescentBio provides a platform that supports decision making in antibody R&D. | Biotech | Leiden | Seed | $378K | 2023-12-05 | $378K | UNIIQ | 1 to 10 | 2023 |
| VivArt-X | VivArt-X creates regenerating materials for women's health. | Biotech | Eindhoven | Pre-seed | $716K | 2023-11-16 | BOM, Brabant Startup Fund | 1 to 10 | 2022 | |
| VectorY | VectorY develops gene therapies for central nervous system, somatic, and muscle diseases. | Biotech | Amsterdam | Series A | $138.0M | 2023-11-13 | $175.6M | Insight Partners, Benhamou Global Ventures, Forbion Capital Partners +2 | 51 to 100 | 2020 |
| Artica Therapeutics | Artica Therapeutics conducts biotechnological research and development for medical devices, pharmaceutical processes, and food. | Biotech | Leiden | Seed | $12.7M | 2023-11-02 | InnovationQuarter, Thuja Capital, BioGeneration Ventures +1 | 1 to 10 | 2020 | |
| Synerkine Pharma | Synerkine Pharma develops fusion proteins for treating chronic pain. | Biotech | Utrecht | Series A | $5.6M | 2023-10-12 | InnovationQuarter, Thuja Capital, Flerie Invest +1 | 1 to 10 | 2009 | |
| Zander Labs | Zander Labs builds neuroadaptive AI that learns from the brain through non-invasive EEG. | Artificial intelligence | Delft | Seed | $866K | 2023-01-15 | JOA Ventures | 11 to 50 | 2016 |
Table 1. Biotech startups in The Netherlands: the 16 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden | Series A | $112.3M | 2026-08-19 | $173.3M | Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures | 11 to 50 | 2023 |
| 2 | Matisse Pharmaceuticals | Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. | Biotech | Geleen | Series A | $16.0M | 2026-09-17 | $22.0M | Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) | 11 to 50 | 2014 |
| 3 | Pan Cancer T | Pan Cancer T develops T-cell receptor therapies for treating solid tumors. | Biotech | Rotterdam | Seed | $5.8M | 2025-12-08 | $16.3M | InnovationQuarter, Thuja Capital, Van Herk Ventures +1 | 1 to 10 | 2020 |
Table 2. Biotech startups in The Netherlands: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | 3 | 2% | 1 | Kynexis |
| 2 | Thuja Capital | Startup accelerator | Utrecht, The Netherlands | 3 | 2% | 1 | Pan Cancer T |
| 3 | InnovationQuarter | Venture capital firm | The Hague, The Netherlands | 3 | 2% | 1 | Pan Cancer T |
| 4 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 2 | 2% | ||
| 5 | Brightlands Venture Partners | Venture capital firm | Geleen, The Netherlands | 2 | 2% | 1 | Matisse Pharmaceuticals |
| 6 | Innovatiefonds Noord-Holland | Venture capital firm | Amsterdam, The Netherlands | 2 | 2% | ||
| 7 | BOM | Government investment office | Tilburg, The Netherlands | 2 | 2% | ||
| 8 | BioGeneration Ventures | Micro VC fund | Naarden, The Netherlands | 2 | 2% | ||
| 9 | UNIIQ | Government investment office | The Hague, The Netherlands | 2 | 2% | ||
| 10 | Kindred Capital | Venture capital firm | London, United Kingdom | 1 | 1% | ||
| 11 | IVP | Venture capital firm | Menlo Park, United States | 1 | 1% | ||
| 12 | Index Ventures | Venture capital firm | San Francisco, United States | 1 | 1% | ||
| 13 | Sunstone Life Science Ventures | Micro VC fund | Copenhagen, Denmark | 1 | 1% | 1 | Kynexis |
| 14 | Ysios Capital | Venture capital firm | San Sebastian, Spain | 1 | 1% | 1 | Kynexis |
| 15 | Eurazeo | Private equity firm | Paris, France | 1 | 1% |
Table 3. Biotech startups in The Netherlands: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 80 | 65% | $1.1B |
| Software | 14 | 11% | $38.1M |
| Artificial intelligence | 7 | 6% | $13.3M |
| Hardware | 7 | 6% | $7.6M |
| Energy | 2 | 2% | |
| Commerce | 1 | 1% | |
| Education | 1 | 1% |
Table 4. Biotech startups in The Netherlands by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in The Netherlands by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Amsterdam | 23 | 19% |
| Leiden | 18 | 15% |
| Utrecht | 8 | 6% |
| Maastricht | 8 | 6% |
| Delft | 7 | 6% |
| Eindhoven | 7 | 6% |
| Geleen | 6 | 5% |
| Wageningen | 6 | 5% |
| Rotterdam | 6 | 5% |
| Groningen | 5 | 4% |
| Nijmegen | 4 | 3% |
| Naarden | 3 | 2% |
Table 6. Biotech startups in The Netherlands by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 8% | $44.9M |
| September 2026 | 2 | 17% | $26.0M |
| August 2026 | 1 | 8% | $112.3M |
| June 2026 | 3 | 25% | $34.5M |
| May 2026 | 1 | 8% | $1.7M |
| March 2026 | 1 | 8% | $6.4M |
| January 2026 | 1 | 8% | $17.5M |
| December 2025 | 2 | 17% | $31.1M |
Table 7. Biotech startups in The Netherlands: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 10 | 8% | $243.4M |
| 2025 | 18 | 15% | $345.7M |
| 2024 | 15 | 12% | $230.1M |
| 2023 | 15 | 12% | $255.8M |
| 2022 | 12 | 10% | $59.5M |
| 2021 | 5 | 4% | $100.0M |
Table 8. Biotech startups in The Netherlands by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 10 | 8% |
| 2020 to 2022 | 30 | 24% |
| 2015 to 2019 | 46 | 37% |
| 2010 to 2014 | 17 | 14% |
| Before 2010 | 20 | 16% |
Table 9. Biotech startups in The Netherlands by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 62 | 52% |
| 11 to 50 | 55 | 46% |
| 51 to 100 | 2 | 2% |
| 501 to 1,000 | 1 | 1% |
Table 10. Biotech startups in The Netherlands by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in The Netherlands. On 16 November 2026 that is 124 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 16 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 124 rows: 27 have no round amount, 0 no city and 52 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in The Netherlands are on the list?
- 124, in the file dated 16 November 2026. 12 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.